DNA Damage inhibitor Kidney Int. 2009;76:422–7 [IVa].PubMedCrossRef 179. Abizaid AS, Clark CE, Mintz Erastin nmr GS, Dosa S, Popma JJ, Pichard AD, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with

preexisting renal insufficiency. Am J Cardiol. 1999;83:260–3 [II].PubMedCrossRef 180. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet. 2000;356:2139–43 [II].PubMedCrossRef 181. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001;29:1526–31 [I].PubMedCrossRef 182. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142:510–24 [I].PubMedCrossRef 183. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002;28:877–83 [I].PubMedCrossRef 184. Ichai C, Passeron C, Carles M, Bouregba M, Grimaud D. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in haemodynamically stable, critically ill patients: a single-blind, prospective, controlled study. Crit Care Med. 2000;28:1329–35 [II].PubMedCrossRef

MLN0128 clinical trial 185. Lauschke A, Teichgraber UK, Frei U, Eckardt KU. Low-dose dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69:1669–74 [II].PubMedCrossRef 186. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, et al. Anaritide in acute tubular necrosis. N Engl J Med. 1997;336:828–34 [II].PubMedCrossRef 187. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, et al. Atrial natriuretic factor in oliguric acute renal failure. Am J Kidney Dis. 2000;36:767–74 [II].PubMedCrossRef 188. Swaerd K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med. 2004;32:1310–5 [II].CrossRef 189. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney

injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:261–72 [I].PubMedCrossRef 190. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume Progesterone continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205–11 [II].PubMedCrossRef 191. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1:915–9 [IVa].PubMedCrossRef 192. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jabber BL. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis.